In the latest in the NFXF Webinar Series, Dr. Tracy King, medical officer in the Intellectual and Developmental Disabilities Branch of the National Institute of Child Health and Human Development (NICHD), and representatives from each of the current Centers.
We heard from the following presenters as they shared their promising research and collaborations:
- Peter Todd and Emily Allen on behalf of Baylor College of Medicine and University of Michigan Medical School
- Peng Jin on behalf of Fragile X Center at Emory University
- Craig Erickson on behalf of Cincinnati Children’s Hospital Medical Center
The Centers for Collaborative Research in Fragile X and FMR1-related Conditions Program supports research to improve the diagnosis and treatment of Fragile X syndrome (FXS) and its related conditions. These Centers are geared toward stimulating multidisciplinary, multi-institutional research, with the common goal of facilitating the translation of basic research findings from bench to bedside and bedside to community.
The program is administered through NICHD’s Intellectual and Developmental Disabilities Branch (IDDB). The branch initially funded three Centers in fiscal year 2003 in response to the Children’s Health Act of 2000.
How to Watch
Enter your name and email address below for your access to the on-demand recording of the webinar:
Recent Posts You May Be Interested In
Lunch & Learn Series: FMR1 Carriers Report Executive Function Changes Prior to FXTAS: A Longitudinal Study
David Hessl, PhD, joined us for a 45-minute webinar where he presented the results of a longitudinal study focusing on executive function changes in people with the FMR1 premutation. The presentation was followed by a moderated Q&A.
A 40 Year History of Supporting Research
The NFXF has worked hard over the past 40 years to increase our understanding of Fragile X-associated conditions and we will continue to do so in the years to come!
A Message from Harmony Biosciences Before the 19th NFXF International Fragile X Conference
Here's a message from our friends at Harmony Biosciences in advance of the 19th NFXF International Fragile X Conference.